学术探索
学术期刊
新闻热点
数据分析
智能评审
立即登录
VERAPAMIL RESTORATION OF DAUNORUBICIN RESPONSIVENESS IN DAUNORUBICIN-RESISTANT EHRLICH ASCITES-CARCINOMA
被引:174
作者
:
SLATER, LM
论文数:
0
引用数:
0
h-index:
0
SLATER, LM
MURRAY, SL
论文数:
0
引用数:
0
h-index:
0
MURRAY, SL
WETZEL, MW
论文数:
0
引用数:
0
h-index:
0
WETZEL, MW
WISDOM, RM
论文数:
0
引用数:
0
h-index:
0
WISDOM, RM
DUVALL, EM
论文数:
0
引用数:
0
h-index:
0
DUVALL, EM
机构
:
来源
:
JOURNAL OF CLINICAL INVESTIGATION
|
1982年
/ 70卷
/ 05期
关键词
:
D O I
:
10.1172/JCI110702
中图分类号
:
R-3 [医学研究方法];
R3 [基础医学];
学科分类号
:
1001 ;
摘要
:
引用
收藏
页码:1131 / 1134
页数:4
相关论文
共 8 条
[1]
CHEN CM, 1979, J PHARMACOL EXP THER, V209, P415
[2]
CHERVINSKY D, 1962, P AM ASS CANCER RES, V13, P56
[3]
DANO K, 1972, CANCER RES, V32, P1307
[4]
ACTIVE OUTWARD TRANSPORT OF DAUNOMYCIN IN RESISTANT EHRLICH ASCITES TUMOR-CELLS
DANO, K
论文数:
0
引用数:
0
h-index:
0
机构:
FINSEN INST, DEPT INTERN MED, DK-2100 COPENHAGEN, DENMARK
FINSEN INST, DEPT INTERN MED, DK-2100 COPENHAGEN, DENMARK
DANO, K
[J].
BIOCHIMICA ET BIOPHYSICA ACTA,
1973,
323
(03)
: 466
-
483
[5]
Fleckenstein A., 1971, CALCIUM HEART, P135
[6]
UPTAKE AND RETENTION OF ADRIAMYCIN AND DAUNORUBICIN BY SENSITIVE AND ANTHRACYCLINE-RESISTANT SUBLINES OF P388-LEUKEMIA
INABA, M
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CHEM PHARMACOL LAB,PROGRAM DEV THERAPEUT,BETHESDA,MD 20014
NCI,DIV CANC TREATMENT,CHEM PHARMACOL LAB,PROGRAM DEV THERAPEUT,BETHESDA,MD 20014
INABA, M
JOHNSON, RK
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CHEM PHARMACOL LAB,PROGRAM DEV THERAPEUT,BETHESDA,MD 20014
NCI,DIV CANC TREATMENT,CHEM PHARMACOL LAB,PROGRAM DEV THERAPEUT,BETHESDA,MD 20014
JOHNSON, RK
[J].
BIOCHEMICAL PHARMACOLOGY,
1978,
27
(17)
: 2123
-
2130
[7]
TRANSPORT AND BINDING OF DAUNORUBICIN, ADRIAMYCIN, AND RUBIDAZONE IN EHRLICH ASCITES TUMOR-CELLS
SKOVSGAARD, T
论文数:
0
引用数:
0
h-index:
0
机构:
FINSEN INST,DEPT INTERNAL MED,DK-2100 COPENHAGEN,DENMARK
FINSEN INST,DEPT INTERNAL MED,DK-2100 COPENHAGEN,DENMARK
SKOVSGAARD, T
[J].
BIOCHEMICAL PHARMACOLOGY,
1977,
26
(03)
: 215
-
222
[8]
TSURUO T, 1981, CANCER RES, V41, P1967
←
1
→
共 8 条
[1]
CHEN CM, 1979, J PHARMACOL EXP THER, V209, P415
[2]
CHERVINSKY D, 1962, P AM ASS CANCER RES, V13, P56
[3]
DANO K, 1972, CANCER RES, V32, P1307
[4]
ACTIVE OUTWARD TRANSPORT OF DAUNOMYCIN IN RESISTANT EHRLICH ASCITES TUMOR-CELLS
DANO, K
论文数:
0
引用数:
0
h-index:
0
机构:
FINSEN INST, DEPT INTERN MED, DK-2100 COPENHAGEN, DENMARK
FINSEN INST, DEPT INTERN MED, DK-2100 COPENHAGEN, DENMARK
DANO, K
[J].
BIOCHIMICA ET BIOPHYSICA ACTA,
1973,
323
(03)
: 466
-
483
[5]
Fleckenstein A., 1971, CALCIUM HEART, P135
[6]
UPTAKE AND RETENTION OF ADRIAMYCIN AND DAUNORUBICIN BY SENSITIVE AND ANTHRACYCLINE-RESISTANT SUBLINES OF P388-LEUKEMIA
INABA, M
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CHEM PHARMACOL LAB,PROGRAM DEV THERAPEUT,BETHESDA,MD 20014
NCI,DIV CANC TREATMENT,CHEM PHARMACOL LAB,PROGRAM DEV THERAPEUT,BETHESDA,MD 20014
INABA, M
JOHNSON, RK
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CHEM PHARMACOL LAB,PROGRAM DEV THERAPEUT,BETHESDA,MD 20014
NCI,DIV CANC TREATMENT,CHEM PHARMACOL LAB,PROGRAM DEV THERAPEUT,BETHESDA,MD 20014
JOHNSON, RK
[J].
BIOCHEMICAL PHARMACOLOGY,
1978,
27
(17)
: 2123
-
2130
[7]
TRANSPORT AND BINDING OF DAUNORUBICIN, ADRIAMYCIN, AND RUBIDAZONE IN EHRLICH ASCITES TUMOR-CELLS
SKOVSGAARD, T
论文数:
0
引用数:
0
h-index:
0
机构:
FINSEN INST,DEPT INTERNAL MED,DK-2100 COPENHAGEN,DENMARK
FINSEN INST,DEPT INTERNAL MED,DK-2100 COPENHAGEN,DENMARK
SKOVSGAARD, T
[J].
BIOCHEMICAL PHARMACOLOGY,
1977,
26
(03)
: 215
-
222
[8]
TSURUO T, 1981, CANCER RES, V41, P1967
←
1
→